Develops cellular reprogramming therapies to restore youthful gene-expression profiles in targeted cells and drive therapeutic organ rejuvenation. Initial focus on single-organ treatments for brain diseases—especially Alzheimer’s—with a long-term aim of multi-organ systemic rejuvenation via tailored therapies.